|
gptkbp:instanceOf
|
oral contraceptive
|
|
gptkbp:activeIngredient
|
gptkb:drospirenone
ethinylestradiol
|
|
gptkbp:alternativeName
|
gptkb:Ocella
gptkb:Syeda
gptkb:Yasminelle
gptkb:Zarah
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
G03AA12
|
|
gptkbp:contraindication
|
gptkb:liver_disease
history of thromboembolic disorders
adrenal insufficiency
renal insufficiency
|
|
gptkbp:countryOfOperation
|
gptkb:Australia
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:drugClass
|
oral contraceptive
|
|
gptkbp:estrogenComponent
|
ethinylestradiol
|
|
gptkbp:form
|
film-coated tablet
drospirenone 3 mg
ethinylestradiol 0.03 mg
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Yasmin (contraceptive)
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Bayer
|
|
gptkbp:marketedAs
|
2001
|
|
gptkbp:mechanismOfAction
|
alters cervical mucus
changes endometrial lining
inhibits ovulation
|
|
gptkbp:notRecommendedFor
|
pregnancy
breastfeeding without medical advice
|
|
gptkbp:pregnancyCategory
|
X
|
|
gptkbp:prescriptionRequired
|
yes
available from Bayer
|
|
gptkbp:progestinComponent
|
gptkb:drospirenone
|
|
gptkbp:riskFactor
|
hyperkalemia
venous thromboembolism
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
headache
breast tenderness
increased risk of blood clots
|
|
gptkbp:storage
|
store below 25°C
|
|
gptkbp:type
|
28 tablets per pack
21 tablets per pack
|
|
gptkbp:usedFor
|
birth control
|
|
gptkbp:website
|
https://www.yasmin-us.com/
|
|
gptkbp:bfsParent
|
gptkb:Bayer_(until_2018)
|
|
gptkbp:bfsLayer
|
7
|